* It analyzed data from 533 adult patients divided into two groups based on different CPB flow rate targets: a low group (>2.2 L/min/m²) and a high group (>2.4 L/min/m²).
* Results showed significant reduction in major adverse kidney events (MAKE) at 30 days in the high flow rate group, which included lower mortality and fewer instances of renal replacement therapy compared to the low flow rate group.